EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Escherichia coli Urinary Tract Infections from a Romanian Pediatric Hospital: Antimicrobial Resistance Trends, ESBL Prevalence, and Empirical Treatment Implications

Daniela Păcurar iD, Alexandru Dinulescu iD, Andrei-Vlad Totu iD, Irina Dijmărescu iD, Mirela-Luminița Pavelescu

Antibiotics · 24.08.2025 · 14 (9) · 855

DOI: 10.3390/antibiotics14090855 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antibiotics, online erschienen am 24.08.2025. Verfasst von Daniela Păcurar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Department of Pediatrics, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Urinary tract infections (UTIs) are among the most common bacterial infections in children, with Escherichia coli as the leading pathogen. The rise in antimicrobial resistance, particularly extended-spectrum β-lactamase (ESBL) production, complicates empirical therapy, especially in countries with limited surveillance like Romania.

Methods

We conducted a retrospective study on 248 pediatric patients aged 0–17 years diagnosed with E. coli UTI and admitted to a children hospital from Bucharest, Romania, between 2022 and 2024. Data collected included clinical presentation, laboratory values, and antimicrobial susceptibility testing. Patients were divided into ESBL and non-ESBL groups, and statistical comparisons were performed using SPSS v25.

Results

Infants accounted for 68.1% of cases, with male sex predominating in this group (85.3%). ESBL-producing strains were identified in 19% of patients, more frequently in males (25% vs. 13.6%, p = 0.024). While inflammatory markers (CRP, leukocytes, neutrophils) were higher in complicated infections, they were paradoxically lower in ESBL cases. Non-ESBL isolates were highly susceptible to fosfomycin, third-generation cephalosporins, nitrofurantoin, and gentamicin. ESBL isolates showed resistance to most β-lactams but retained high susceptibility to fosfomycin (100%), carbapenems (>89%), cefoxitin (89.4%), and amikacin (85.1%).

Conclusions

Our findings support the use of fosfomycin, nitrofurantoin, and selected aminoglycosides as viable empirical options in pediatric UTIs. Given the substantial ESBL prevalence and resistance to commonly used oral agents, local antibiogram data should guide empirical treatment strategies to preserve antibiotic efficacy and combat resistance.

Schlagwörter

Stichwörter der Autor:innen

ESBLEscherichia coliRomaniaantimicrobial resistancecarbapenemsempirical treatmentfosfomycinnitrofurantoinpediatricurinary tract infection

Autor:innen und Institutionen

  • Faculty of Medicine, Department of Pediatrics, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
  • Department of Pediatrics, Emergency Hospital for Children "Grigore Alexandrescu", 011743 Bucharest, Romania.

ORCID-Profile: Daniela Păcurar, Alexandru Dinulescu, Andrei-Vlad Totu, Irina Dijmărescu

Zitieren

APA

Păcurar, D., Dinulescu, A., Totu, A. V., Dijmărescu, I., & Pavelescu, M. L. (2025). Escherichia coli Urinary Tract Infections from a Romanian Pediatric Hospital: Antimicrobial Resistance Trends, ESBL Prevalence, and Empirical Treatment Implications. Antibiotics, 14(9), 855. https://doi.org/10.3390/antibiotics14090855

Vancouver

Păcurar D, Dinulescu A, Totu AV, Dijmărescu I, Pavelescu ML. Escherichia coli Urinary Tract Infections from a Romanian Pediatric Hospital: Antimicrobial Resistance Trends, ESBL Prevalence, and Empirical Treatment Implications. Antibiotics. 2025;14(9):855. doi:10.3390/antibiotics14090855

BibTeX
@article{Pcurar2025,
  author = {Păcurar, Daniela and Dinulescu, Alexandru and Totu, Andrei-Vlad and Dijmărescu, Irina and Pavelescu, Mirela-Luminița},
  title = {Escherichia coli Urinary Tract Infections from a Romanian Pediatric Hospital: Antimicrobial Resistance Trends, ESBL Prevalence, and Empirical Treatment Implications},
  journal = {Antibiotics},
  year = {2025},
  volume = {14},
  number = {9},
  pages = {855},
  doi = {10.3390/antibiotics14090855}
}
Kostenlos starten →